v3.26.1
Share-based compensation
9 Months Ended
Mar. 27, 2026
Share-Based Payment Arrangement [Abstract]  
Share-based compensation Share-based compensation
Share-based compensation
The grant date fair value of restricted share units and performance share units is based on the market value of Fabrinet's ordinary shares on the date of grant.
The effect of recording share-based compensation expense for the three and nine months ended March 27, 2026 and March 28, 2025 was as follows:
 Three Months EndedNine Months Ended
(in thousands)March 27,
2026
March 28,
2025
March 27,
2026
March 28,
2025
Share-based compensation expense by type of award:  
Restricted share units$5,184 $4,777 $16,887 $15,920 
Performance share units3,357 3,006 9,482 8,983 
Total share-based compensation expense8,541 7,783 26,369 24,903 
Tax effect on share-based compensation expense— — — — 
Net effect on share-based compensation expense$8,541 $7,783 $26,369 $24,903 
Share-based compensation expense was recorded in the unaudited condensed consolidated statements of operations and comprehensive income as follows:
 Three Months EndedNine Months Ended
(in thousands)March 27,
2026
March 28,
2025
March 27,
2026
March 28,
2025
Cost of revenue$2,531 $2,221 $8,694 $7,883 
Selling, general and administrative expense6,010 5,562 17,675 17,020 
Total share-based compensation expense$8,541 $7,783 $26,369 $24,903 
The Company did not capitalize any share-based compensation expense as part of any asset costs during the three and nine months ended March 27, 2026 and March 28, 2025.
Share-based award activity
On December 12, 2019, the Company’s shareholders approved Fabrinet’s 2020 Equity Incentive Plan (the “2020 Plan”). Upon the approval of the 2020 Plan, Fabrinet’s Amended and Restated 2010 Performance Incentive Plan (the “2010 Plan”) was simultaneously terminated. The 2020 Plan provides for the grant of equity awards thereunder with respect to (i) 1,700,000 ordinary shares, plus (ii) up to 1,300,000 ordinary shares that, as of immediately prior to the termination of the 2010 Plan, had been reserved but not issued pursuant to any awards granted under the 2010 Plan and are not subject to any awards thereunder. Upon termination of the 2010 Plan, 1,281,619 ordinary shares were reserved for issuance under the 2020 Plan pursuant to clause (ii) of the preceding sentence.
On November 2, 2017, the Company adopted the 2017 Inducement Equity Incentive Plan (the “2017 Inducement Plan”) with a reserve of 160,000 ordinary shares authorized for future issuance solely for the granting of inducement share options and equity awards to new employees. The 2017 Inducement Plan was adopted without shareholder approval in reliance on the “employment inducement exemption” provided under the New York Stock Exchange Listed Company Manual. 
The 2020 Plan and 2017 Inducement Plan are collectively referred to as the “Equity Incentive Plans.”
The following table summarizes the number of equity awards outstanding and ordinary shares available for grant under each of the Equity Incentive Plans as of March 27, 2026:
(share units)Restricted Share Units outstandingPerformance Share Units outstandingOrdinary Shares available for future grant
2020 Plan217,526 95,196 1,458,348 
2017 Inducement Plan— — 111,347 
Total217,526 95,196 1,569,695 
Restricted share units and performance share units
Restricted share units and performance share units have been granted under the Equity Incentive Plans.
Restricted share units granted to employees generally vest in equal installments over three or four years on each anniversary of the vesting commencement date. Restricted share units granted to non-employee directors generally cliff vest 100% on the first of January, approximately one year from the grant date, provided the director continues to serve through such date.
Performance share units granted to executives will vest, if at all, at the end of a two-year performance period based on the Company’s achievement of pre-defined performance criteria, which consist of revenue and non-GAAP operating margin targets. The actual number of performance share units that may vest at the end of the performance period ranges from 0% to 100% of the award grant.
The following table summarizes restricted share unit activity under the Equity Incentive Plans:
 Number
of
Shares
Weighted-
Average Grant
Date Fair Value
Per Share
Balance as of June 27, 2025
263,014 $187.00 
Granted76,492 $299.63 
Vested(113,827)$167.65 
Forfeited(8,153)$227.15 
Balance as of March 27, 2026
217,526 $236.16 
 Number
of
Shares
Weighted-
Average Grant
Date Fair Value
Per Share
Balance as of June 28, 2024306,660 $129.01 
Granted111,922 $259.19 
Vested(132,797)$118.43 
Forfeited(15,297)$165.48 
Balance as of March 28, 2025
270,488 $186.00 
The following table summarizes performance share unit activity under the Equity Incentive Plans:
 Number
of
Shares
Weighted-
Average Grant
Date Fair Value
Per Share
Balance as of June 27, 2025
120,916 $198.90 
Granted48,806 $277.04 
Vested(73,936)$158.91 
Forfeited(590)$261.84 
Balance as of March 27, 2026
95,196 $269.63 
 Number
of
Shares
Weighted-
Average Grant
Date Fair Value
Per Share
Balance as of June 28, 2024171,078 $135.31 
Granted46,980 $261.84 
Vested(97,142)117.35 
Forfeited— $— 
Balance as of March 28, 2025
120,916 $198.90 
As of March 27, 2026, there was $21.2 million and $11.0 million of unrecognized share-based compensation expense related to restricted share units and performance share units, respectively, under the Equity Incentive Plans that is expected to be recorded over a weighted-average period of 2.6 and 1.2 years, respectively.
For the nine months ended March 27, 2026 and March 28, 2025, the Company withheld an aggregate of 72,850 shares and 90,792 shares, respectively, upon the vesting of restricted share units and performance shares units, based upon the closing share price on the vesting date to settle employee tax withholding obligations. For the nine months ended March 27, 2026 and March 28, 2025, the Company then remitted cash of $24.4 million and $20.9 million, respectively, to the appropriate taxing authorities and presented it as a financing activity within the unaudited condensed consolidated statements of cash flows. The payment was recorded as a reduction of additional paid-in capital.
Customer Warrant
On March 12, 2025, the Company issued a warrant (the “Warrant”) to Amazon.com NV Investment Holdings LLC to acquire up to 381,922 ordinary shares (the “Warrant Shares”) of the Company at an exercise price of $208.48 per share. The Warrant allows for cashless exercise and expires on March 12, 2032.
Upon issuance of the Warrant, 38,192 of the Warrant Shares vested. The remainder of the Warrant Shares are subject to vesting in multiple tranches over the term of the Warrant based on payments to the Company from or on behalf of Amazon.com, Inc. ("Amazon") or its affiliates under a commercial agreement or otherwise. Upon the consummation of an acquisition transaction or the termination of the commercial agreement by Amazon for cause, the unvested portion of the Warrant will vest in full. The exercise price and the number of Warrant Shares are subject to customary antidilution adjustments.
Using the Black-Scholes option pricing model, the grant date fair value of the Warrant was determined to be $102.88 per share, for a total fair value of $39.3 million. The grant date fair value of the Warrant was estimated as of the issuance date using the following assumptions:
Expected dividend yield— 
Risk-free interest rate3.8 %
Expected volatility45.2 %
Expected term (in years)7 years
As of March 27, 2026 and June 27, 2025, 70,662 and 38,192 Warrant Shares, respectively, were vested and remained unexercised.